Pseudobulbar Affect (PBA)

See the following -

Avanir Pharmaceuticals Presents Data From A Benchmark Study Of PBA Symptoms In Veterans With Mild Traumatic Brain Injury

Press Release | Avanir Pharmaceuticals, Inc. | March 19, 2014

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the presentation of results from a first-of-its-kind study of pseudobulbar affect (PBA) symptoms in veterans with mild traumatic brain injury (TBI) conducted in collaboration with the Department of Veterans Affairs (VA) and Evidera. Read More »